Walleye Capital LLC Ab Cellera Biologics Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 15,000 shares of ABCL stock, worth $37,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 256,881
94.16%
Holding current value
$37,800
Previous $665,000
93.53%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABCL
# of Institutions
165Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$69.4 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$30.8 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$26.8 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$20 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$18.5 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $719M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...